| Unique ID issued by UMIN | UMIN000061549 |
|---|---|
| Receipt number | R000070429 |
| Scientific Title | Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial |
| Date of disclosure of the study information | 2026/05/13 |
| Last modified on | 2026/05/13 11:29:01 |
Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial
Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial
Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial
Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial
| Japan |
Minor surgical conditions, primarily including superficial bladder cancer
| Anesthesiology | Operative medicine |
Malignancy
NO
To demonstrate that the use of lung-protective ventilation during general anesthesia reduces upper airway-related complications.
To evaluate the effects of lung-protective ventilation on the upper airway, particularly on glottic patency.
Efficacy
Incidence of capnography-detected abnormalities in end-tidal carbon dioxide waveforms immediately after neuromuscular blockade reversal under supraglottic airway device management
Glottic angle observed fiberoptically through a supraglottic airway device
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
No treatment
2
Treatment
| Maneuver |
Lung-protective ventilation group (5 mL/kg)
Conventional ventilation group (8 mL/kg)
| 18 | years-old | <= |
| Not applicable |
Male and Female
1)Adults aged >=18 years at the time of consent.
2)Adult patients scheduled to undergo minor surgical procedures under general anesthesia managed with a supraglottic airway device.
3)Patients who have received a full explanation of the study, have adequately understood it, and have provided written informed consent voluntarily.
Patients meeting any of the following criteria:
1)Patients whose upper airway is managed with devices other than a supraglottic airway device.
2)Patients who have withdrawn consent and expressed refusal to participate in this study.
3)Patients with severe hepatic dysfunction.
4)Patients in whom succinylcholine is contraindicated.
5)Patients deemed unsuitable for the study by the principal investigator.
80
| 1st name | Katsuhiko |
| Middle name | |
| Last name | Ishibashi |
Institute of Science Tokyo Hospital
Anesthesiology
113-8510
1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
03-3813-6111
ishibashi.k.3dd4@m.isct.ac.jp
| 1st name | Katsuhiko |
| Middle name | |
| Last name | Ishibashi |
Institute of Science Tokyo Hospital
Anesthesiology
113-8510
1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
03-3813-6111
ishibashi.k.3dd4@m.isct.ac.jp
Institute of Science Tokyo
Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Japanese Governmental office
Medical Research Ethics Committee of Institute of Science Tokyo
1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
03-5803-4547
rinri.adm@tmd.ac.jp
YES
jRCT1030250783
Japan Registry of Clinical Trials
東京科学大学病院(東京都)
| 2026 | Year | 05 | Month | 13 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 03 | Month | 06 | Day |
| 2026 | Year | 02 | Month | 24 | Day |
| 2026 | Year | 04 | Month | 01 | Day |
| 2030 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 05 | Month | 13 | Day |
| 2026 | Year | 05 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070429